{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:31:47Z","timestamp":1779327107247,"version":"3.51.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008021","name":"Bristol-Myers Squibb Canada","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>We evaluated the effect of abatacept treatment on osteoclast-related biomarkers and explored whether the biomarkers are associated with the therapeutic response in rheumatoid arthritis (RA) patients treated with abatacept.<\/jats:p>\n            <jats:p>We enrolled 44 RA patients treated with abatacept from a multicenter prospective ultrasound cohort study of patients who received biologic or targeted synthetic disease-modifying antirheumatic drug therapy. We evaluated the disease activity score (DAS) 28-CRP (C-reactive protein), musculoskeletal ultrasound scores including the total grayscale score (GS)\/power Doppler (PD) score and the serum concentrations of isoform 5b of tartrate-resistant acid phosphate (TRACP-5b) and soluble receptor activator of nuclear factor-\u03baB ligand (sRANKL) at baseline and at 3 and 6\u200amonths of treatment. \u201cPD responder\u201d was defined as a patient whose \u0394total PD score over 6\u200amonths was greater than the median change of that.<\/jats:p>\n            <jats:p>Abatacept significantly improved DAS28-CRP as well as the total GS\/PD score over 6\u200amonths. Serum TRACP-5b was significantly elevated and serum sRANKL was significantly decreased at 6\u200amonths (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.0001 and <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.01, respectively). At 6\u200amonths, serum sRANKL was significantly decreased in the patients who achieved DAS28-CRP remission and the PD responders but not in those who did not. However, serum TRACP-5b rose regardless of the therapeutic response.<\/jats:p>\n            <jats:p>Among RA patients treated with abatacept, serum sRANKL decreased in the patients with a good therapeutic response, but serum TRACP-5b elevated paradoxically regardless of the therapeutic response.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026592","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T21:08:54Z","timestamp":1626296934000},"page":"e26592","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Effect of abatacept treatment on serum osteoclast-related biomarkers in patients with rheumatoid arthritis (RA)"],"prefix":"10.1097","volume":"100","author":[{"given":"Shin-Ya","family":"Kawashiri","sequence":"first","affiliation":[{"name":"Departments of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"},{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushiro","family":"Endo","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nishino","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sosuke","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuko","family":"Takatani","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remi","family":"Sumiyoshi","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Tamai","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Origuchi","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Aramaki","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitaka","family":"Ueki","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study (KUDOS) Group, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamami","family":"Yoshitama","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study (KUDOS) Group, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Eiraku","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study (KUDOS) Group, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study (KUDOS) Group, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitomo","family":"Okada","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study (KUDOS) Group, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Fujikawa","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study (KUDOS) Group, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Hamada","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study (KUDOS) Group, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Nagano","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study (KUDOS) Group, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Tada","sequence":"additional","affiliation":[{"name":"Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study (KUDOS) Group, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"R2-20250504","first-page":"551","article-title":"One year in review: the pathogenesis of rheumatoid arthritis","volume":"33","author":"Picerno","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14397595.2016.1265907","article-title":"Autoimmunity as a trigger for structural bone damage in rheumatoid arthritis","volume":"27","author":"Schett","year":"2017","journal-title":"Mod Rheumatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3389\/fimmu.2019.01483","article-title":"How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis","volume":"10","author":"Steffen","year":"2019","journal-title":"Front Immunol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00198-016-3769-2","article-title":"Biologic therapies and bone loss in rheumatoid arthritis","volume":"28","author":"Zerbini","year":"2017","journal-title":"Osteoporos Int"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"03","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/art.10294","article-title":"Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion","volume":"46","author":"Moreland","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2014-206106","article-title":"Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24\u200amonths, with a 12-month, double-blind treatment period","volume":"74","author":"Emery","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/annrheumdis-2013-203843","article-title":"Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial","volume":"73","author":"Schiff","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1136\/ard.2010.139345","article-title":"Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial","volume":"70","author":"Kremer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/ard.2010.145268","article-title":"Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes","volume":"70","author":"Bathon","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"e000813","DOI":"10.1136\/rmdopen-2018-000813","article-title":"Abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study","volume":"4","author":"Matsubara","year":"2018","journal-title":"RMD Open"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13075-020-2100-y","article-title":"Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors-data from a large national quality register","volume":"22","author":"Cagnotto","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1136\/ard.2007.080713","article-title":"CTLA-4 directly inhibits osteoclast formation","volume":"67","author":"Axmann","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"235ra60","DOI":"10.1126\/scitranslmed.3007764","article-title":"T cell costimulation molecules CD80\/86 inhibit osteoclast differentiation by inducing the IDO\/tryptophan pathway","volume":"6","author":"Bozec","year":"2014","journal-title":"Sci Transl Med"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/jbmr.3754","article-title":"CTLA4-Ig directly inhibits osteoclastogenesis by interfering with intracellular calcium oscillations in bone marrow macrophages","volume":"34","author":"Okada","year":"2019","journal-title":"J Bone Miner Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/cei.13271","article-title":"Tumour necrosis factor ( augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression","volume":"196","author":"Oi","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5152\/eurjrheum.2017.17006","article-title":"Paradoxical elevation of serum TRACP5b levels despite increase in lumbar spine bone mineral density during anti-TNF\u03b1 therapy in patients with inflammatory rheumatic disease: a 2-year prospective assessment of bone mass, bone metabolism, and the trabecular bone score","volume":"4","author":"Toussirot","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/annrheumdis-2012-203158","article-title":"EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis","volume":"72","author":"Colebatch","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1136\/annrheumdis-2016-209646","article-title":"Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission","volume":"75","author":"D\u2019Agostino","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/acr.23551","article-title":"Ultrasonographic efficacy of biologic and targeted synthetic disease-modifying antirheumatic drug therapy in rheumatoid arthritis from a multicenter rheumatoid arthritis ultrasound prospective cohort in Japan","volume":"70","author":"Nishino","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/03009742.2019.1627411","article-title":"Anti-citrullinated protein antibody titre as a predictor of abatacept treatment persistence in patients with rheumatoid arthritis: a prospective cohort study in Japan","volume":"49","author":"Endo","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/25785826.2020.1757920","article-title":"TNF inhibitor cyclers from multicentre rheumatoid arthritis ultrasonography prospective cohort in Japan","volume":"43","author":"Endo","year":"2020","journal-title":"Immunol Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"e000237","DOI":"10.1136\/rmdopen-2015-000237","article-title":"Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study","volume":"2","author":"D\u2019Agostino","year":"2016","journal-title":"RMD Open"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"e000564","DOI":"10.1136\/rmdopen-2017-000564","article-title":"Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study","volume":"4","author":"Jansen","year":"2018","journal-title":"RMD Open"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2017.01.014","article-title":"Effects of targeted therapies on the bone in arthritides","volume":"16","author":"Szentp\u00e9tery","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1359\/jbmr.080329","article-title":"Significance of serum TRACP in rheumatoid arthritis","volume":"23","author":"Janckila","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/TCRM.S156350","article-title":"Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis","volume":"14","author":"Suzuki","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1359\/JBMR.050403","article-title":"Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover","volume":"20","author":"Nenonen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R33-20250504","first-page":"943","article-title":"Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis","volume":"152","author":"Gravallese","year":"1998","journal-title":"Am J Pathol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/art.38319","article-title":"CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model","volume":"66","author":"Roser-Page","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-017-3922-z","article-title":"Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study","volume":"38","author":"Tada","year":"2018","journal-title":"Rheumatol Int"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/14397595.2015.1123211","article-title":"Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis","volume":"26","author":"Harigai","year":"2016","journal-title":"Mod Rheumatol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/14397595.2018.1524998","article-title":"Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance","volume":"29","author":"Harigai","year":"2019","journal-title":"Mod Rheumatol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00774-007-0826-0","article-title":"Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjects","volume":"26","author":"Nishizawa","year":"2008","journal-title":"J Bone Miner Metab"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:38:26Z","timestamp":1746337106000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026592"}},"subtitle":["A multicenter RA ultrasound prospective cohort in Japan"],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":38,"journal-issue":{"issue":"28","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026592","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"2020-08-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}